Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118229) titled 'A prospective, multicenter, randomized, positive controlled clinical trial of rapamycin drug-coated intracranial stents for endovascular treatment of symptomatic intracranial atherosclerotic stenosis' on Feb. 3.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shanghai East Hospital

Condition: Symptomatic intracranial atherosclerotic stenosis

Intervention: Test Group:Intracranial stents coated with rapamycin were used

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2024-12-30

Target Sample Size: Test Group:59;Control group:59;

Countries of Recruitment: C...